Association of Gene Polymorphisms in CYP2C19, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients undergoing percutaneous coronary intervention
ConclusionHPR is associated with increased rates of ischemic event only in patients with high SS suggesting a possible setting in which platelet function testing could be implemented to optimise antiplatelet therapy. CYP2C19*2was the only genetic variant significantly associated HPR but not associated with the risk of MACE.
Source: Journal of Indian College of Cardiology - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Clopidogrel | Coronary Angioplasty | Genetics | Heart | India Health | Percutaneous Coronary Intervention | Plavix